Index of reports
> Cases with Haemarthrosis (3)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Kogenate (Antihemophilic Factor) where reactions include haemarthrosis. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Kogenate side effects in 43 year old male
Reported by a pharmacist from United States on 2012-06-12
Patient: 43 year old male, weighing 45.4 kg (99.8 pounds)
Reactions: Haemarthrosis, Haemorrhage, Factor Viii Inhibition
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Kogenate
Kogenate
Kogenate
Dosage: 4-6 units/kg/hr continuous infusio iv drip
Indication: Haemorrhage
Start date: 2011-10-10
End date: 2011-10-14
Kogenate
Dosage: 4 units/kg/hr continuous infusio iv drip
Indication: Haemorrhage
Start date: 2011-06-27
End date: 2011-06-30
Other drugs received by patient: Advate
Possible Kogenate side effects in 69 year old male
Reported by a pharmacist from United States on 2012-06-08
Patient: 69 year old male, weighing 88.0 kg (193.6 pounds)
Reactions: Product Quality Issue, Haemorrhage, Haemarthrosis, Haematuria, Coronary Artery Disease, Factor Viii Inhibition, Weight Bearing Difficulty, NO Therapeutic Response, Chest Pain
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Kogenate
Dosage: 4-5units/kg/hr continuous infusion iv drip
Indication: Factor Viii Deficiency
Start date: 2012-02-08
End date: 2012-02-14
Kogenate
Dosage: 4-5units/kg/hr continuous infusion iv drip
Indication: Haemorrhage
Start date: 2012-02-08
End date: 2012-02-14
Kogenate
Dosage: 6units/kg/hr continuous infusion iv drip
Start date: 2012-03-01
End date: 2012-03-02
Possible Kogenate side effects in 23 year old male
Reported by a pharmacist from United States on 2012-06-08
Patient: 23 year old male, weighing 75.0 kg (165.0 pounds)
Reactions: Product Quality Issue, Therapeutic Response Decreased, Haemarthrosis, Factor Viii Inhibition
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Kogenate
Dosage: 4-5 units/kg/hr continuous infusion iv drip
Start date: 2012-04-06
End date: 2012-04-10
Kogenate
Dosage: 4 units/kg/hr continuous infusion iv drip
Indication: Factor Viii Deficiency
Start date: 2012-03-11
End date: 2012-03-14
|